BRIACELL THERAPEUTICS CORP (BCTX)
CA1079301091 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A | |||||||||||||
| EBITDA YoY % growth | -440K | -470K -6.82% | N/A | -1.688M | -2.344M -38.90% | -3.613M -54.12% | -4.519M -25.08% | -3.547M 21.50% | -6.961M -96.22% | -15.274M -119.42% | -23.257M -52.27% | -33.246M -42.95% | N/A | N/A | N/A | |
| EBIT YoY % growth | -440K | -470K -6.82% | -3.548M -654.98% | -1.689M 52.41% | -2.344M -38.83% | -3.625M -54.63% | -4.533M -25.03% | -3.561M 21.44% | -6.976M -95.89% | -15.289M -119.16% | -23.272M -52.22% | -33.33M -43.22% | N/A -45.61% | N/A -33.40% | N/A -14.20% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | -1.30 -26.19% | -1.17 10.00% | N/A 20.58% | N/A 57.61% | N/A 25.64% |
All data in USD
| Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|
| EPS Q2Q % growth | -0.30 39.40% | -0.21 70.13% | -0.19 -274.45% | -0.17 -145.29% |
| Revenue Q2Q % growth | ||||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -10.706M -25.91% | -11.817M -20.22% | -13.029M -41.16% | -14.241M -146.90% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2024 Q2Q % growth | -0.07 50.00% | -0.53 | 0.46 | 86.67% |
| Q3 2024 Q2Q % growth | 0.11 134.38% | -0.56 | 0.67 | 119.80% |
| Q2 2024 Q2Q % growth | -0.71 7.79% | -0.20 | -0.51 | -251.49% |
| Q1 2024 Q2Q % growth | -0.50 -614.29% | -0.18 | -0.32 | -175.03% |
| Q4 2023 Q2Q % growth | -0.14 86.27% | -0.40 | 0.26 | 65.35% |
| Q3 2023 Q2Q % growth | -0.32 | -0.36 | 0.04 | 10.75% |
| Q2 2023 Q2Q % growth | -0.77 -220.83% | -0.36 | -0.41 | -114.75% |
| Q1 2023 Q2Q % growth | -0.07 | -0.33 | 0.26 | 79.00% |
| Q4 2022 Q2Q % growth | -1.02 | -0.31 | -0.71 | -231.12% |
| Q3 2022 Q2Q % growth | -0.32 | -0.19 | -0.13 | -66.75% |
| Q2 2022 Q2Q % growth | -0.24 | -0.17 | -0.07 | -44.01% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | N/A | 0% | 8% |
| Revenue | N/A | N/A | N/A | N/A |